Literature DB >> 19605876

Life-threatening allergic bronchopulomnary aspergillosis treated with methylprednisolone and anti-IgE monoclonal antibody.

Matthew F Thomas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19605876      PMCID： PMC2711859          DOI： 10.1258/jrsm.2009.s19011

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  12 in total

1.  Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

Authors:  H Milgrom; R B Fick; J Q Su; J D Reimann; R K Bush; M L Watrous; W J Metzger
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

2.  Survey of criteria used to diagnose allergic bronchopulmonary aspergillosis in cystic fibrosis.

Authors:  S Cunningham; S L Madge; R Dinwiddie
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

3.  Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.

Authors:  G Mastella; M Rainisio; H K Harms; M E Hodson; C Koch; J Navarro; B Strandvik; S G McKenzie
Journal:  Eur Respir J       Date:  2000-09       Impact factor: 16.671

Review 4.  Anti-IgE for chronic asthma in adults and children.

Authors:  S Walker; M Monteil; K Phelan; T J Lasserson; E H Walters
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

5.  Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis.

Authors:  Emma Skowronski; Dominic A Fitzgerald
Journal:  Med J Aust       Date:  2005-05-02       Impact factor: 7.738

6.  Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.

Authors:  Richard Kraemer; Natascha Deloséa; Pietro Ballinari; Sabina Gallati; Reto Crameri
Journal:  Am J Respir Crit Care Med       Date:  2006-09-07       Impact factor: 21.405

7.  Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis.

Authors:  Janine M Thomson; Alison Wesley; Catherine A Byrnes; Gillian M Nixon
Journal:  Pediatr Pulmonol       Date:  2006-02

Review 8.  Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference.

Authors:  David A Stevens; Richard B Moss; Viswanath P Kurup; Alan P Knutsen; Paul Greenberger; Marc A Judson; David W Denning; Reto Crameri; Alan S Brody; Michael Light; Marianne Skov; William Maish; Gianni Mastella
Journal:  Clin Infect Dis       Date:  2003-10-01       Impact factor: 9.079

9.  Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.

Authors:  Ratko Djukanović; Susan J Wilson; Monica Kraft; Nizar N Jarjour; Mark Steel; K Fan Chung; Weibin Bao; Angel Fowler-Taylor; John Matthews; William W Busse; Stephen T Holgate; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2004-06-01       Impact factor: 21.405

10.  Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.

Authors:  Jacquelyn M Zirbes; Carlos E Milla
Journal:  Pediatr Pulmonol       Date:  2008-06
View more
  2 in total

Review 1.  Severe asthma with fungal sensitization.

Authors:  Ritesh Agarwal
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

Review 2.  Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis.

Authors:  Birce Sunman; Dilber Ademhan Tural; Beste Ozsezen; Nagehan Emiralioglu; Ebru Yalcin; Uğur Özçelik
Journal:  Front Pediatr       Date:  2020-10-20       Impact factor: 3.418
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.